HKD 10.4
(-2.07%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 1.22 Billion CNY | 7.73% |
2022 | 1.05 Billion CNY | 16.95% |
2021 | 901.43 Million CNY | 25.65% |
2020 | 717.43 Million CNY | -6.86% |
2019 | 770.3 Million CNY | -0.54% |
2018 | 774.44 Million CNY | 22.15% |
2017 | 632.84 Million CNY | 7.68% |
2016 | 591.18 Million CNY | 7.4% |
2015 | 548.59 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 526.2 Million CNY | 0.0% |
2023 FY | - CNY | 7.73% |
2023 Q4 | 528.03 Million CNY | 0.0% |
2023 Q2 | 444.87 Million CNY | 0.0% |
2022 Q4 | 644.64 Million CNY | 0.0% |
2022 Q2 | 412.99 Million CNY | 0.0% |
2022 FY | - CNY | 16.95% |
2021 Q2 | 359 Million CNY | 0.0% |
2021 Q4 | 542.42 Million CNY | 0.0% |
2021 FY | - CNY | 25.65% |
2020 FY | - CNY | -6.86% |
2020 Q4 | 484.19 Million CNY | 0.0% |
2020 Q2 | 233.23 Million CNY | 0.0% |
2019 Q4 | 403.75 Million CNY | 0.0% |
2019 FY | - CNY | -0.54% |
2019 Q2 | 366.55 Million CNY | 0.0% |
2018 Q2 | 309.01 Million CNY | 0.0% |
2018 FY | - CNY | 22.15% |
2018 Q4 | 361.37 Million CNY | 0.0% |
2017 Q2 | 222.06 Million CNY | 0.0% |
2017 FY | - CNY | 7.68% |
2017 Q4 | 355.5 Million CNY | 0.0% |
2016 Q1 | 104.69 Million CNY | 0.0% |
2016 Q4 | 107.16 Million CNY | 0.0% |
2016 Q2 | 104.69 Million CNY | 0.0% |
2016 FY | - CNY | 7.4% |
2015 FY | - CNY | 0.0% |
2015 Q3 | 98.1 Million CNY | 0.0% |
2015 Q4 | 104.69 Million CNY | 6.72% |
2015 Q1 | 98.1 Million CNY | 0.0% |
2015 Q2 | 98.1 Million CNY | 0.0% |
2014 Q4 | 98.1 Million CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Vincent Medical Holdings Limited | 104.43 Million HKD | -1071.03% |